✦ LIBER ✦

Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology

✍ Scribed by G. Northoff

Publisher: Springer
Year: 2002
Tongue: English
Weight: 110 KB
Volume: 109
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s00702-002-0762-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroleptic malignant syndrome and catat

Neuroleptic malignant syndrome and catatonia

✍ Michele Raja; Maria Concetta Altavista; Stefano Cavallari; Loredana Lubich 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 611 KB

Neoplasia and the neuroleptic malignant

Neoplasia and the neuroleptic malignant syndrome

✍ P. W. R. Wooduff; E. Palazidou; I. Cranston; B. K. Toone; B. Summers; A. L. W. F 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

## Abstract The association of neuroleptic malignant syndrome with neoplasia has not been previously reported. We report the case of a 64‐year‐old female patient who developed the classical picture of neuroleptic malignant syndrome in relation to a uterine leiomyosarcoma. This raises the question a

Neuroleptic malignant syndrome: Mechanis

Neuroleptic malignant syndrome: Mechanisms, interactions, and causality

✍ P. Ken Gillman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract This review focuses on new data from recent publications concerning how compounding interactions between different thermoregulatory pathways influence the development of hyperthermia and/or neuroleptic malignant syndrome (NMS), and the fundamental issue of the presumed causal role of an

Neuroleptic malignant syndrome: A compli

Neuroleptic malignant syndrome: A complication of neuroleptics and cocaine abuse

✍ MaCaulay J. Akpaffiong; Pedro Ruiz 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 710 KB

Neuroleptic malignant syndrome and hyper

Neuroleptic malignant syndrome and hyperosmolar, non-ketotic hyperglycaemic coma

✍ Short, J A ;Nolan, J A 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Clinical risk factors for neuroleptic ma

Clinical risk factors for neuroleptic malignant syndrome

✍ Domenico Berardi; Maddalena Dell'Atti; Mario Amore; Diana De Ronchi; Giuseppe Fe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Pharmacological risk factors for neuroleptic malignant syndrome (NMS) are better defined than clinical risk factors. We examined the psychopathological status preceding the onset of NMS in 20 patients. We evaluated four key psychiatric symptoms (psychomotor agitation, catatonia, disorganization and